1. Home
  2. KWR vs HROW Comparison

KWR vs HROW Comparison

Compare KWR & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quaker Houghton

KWR

Quaker Houghton

HOLD

Current Price

$128.27

Market Cap

2.0B

Sector

Industrials

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$37.91

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KWR
HROW
Founded
1918
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
KWR
HROW
Price
$128.27
$37.91
Analyst Decision
Buy
Strong Buy
Analyst Count
5
8
Target Price
$159.75
$69.86
AVG Volume (30 Days)
153.1K
475.4K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
1.59%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,888,634,000.00
N/A
Revenue This Year
$5.31
$31.79
Revenue Next Year
$4.02
$49.04
P/E Ratio
N/A
N/A
Revenue Growth
2.66
N/A
52 Week Low
$98.26
$21.18
52 Week High
$183.01
$54.98

Technical Indicators

Market Signals
Indicator
KWR
HROW
Relative Strength Index (RSI) 47.43 52.71
Support Level $125.96 $36.23
Resistance Level $127.86 $41.49
Average True Range (ATR) 4.69 1.53
MACD 1.87 0.76
Stochastic Oscillator 77.04 86.46

Price Performance

Historical Comparison
KWR
HROW

About KWR Quaker Houghton

Quaker Houghton manufactures and sells a variety of industrial process fluids. The company's product portfolio includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals. The company's geographic segments include the Americas, EMEA, and Asia/Pacific. The majority of the company's revenue is earned from the Americas.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: